Norway· NO-ID_6CBDA88B-AB13-4893-8E75-91C826F835A4

Gonasi Set

A chorionic gonadotrophin product containing chorionic gonadotrophin + human, registered in Norway by IBSA Farmaceutici Italia S.r.l.. The same ATC class is registered in 12 of our 19 countries.

ATC G03GA01

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedGonasi SetATCG03GA01REGISTER NO.NO-ID_6CBDA88B-AB13-4…PACKS LISTED3CHECKEDSeptember 25, 2026

Where it is registered

Chorionic gonadotrophin is registered in 12 of 19 countries.

Countries holding a registration under ATC G03GA01 (chorionic gonadotrophin), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 6 of them publish a price we can compare per daily dose

Chorionic gonadotrophin · ATC G03GA01

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FEST (Norway)
Active substance
Chorionic Gonadotrophin + Human
Manufacturer
IBSA Farmaceutici Italia S.r.l.
Country
Norway (NO)
ATC code
G03GA01
ATC class
Chorionic gonadotrophin
Defined daily dose
7.5 TSD, E
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
September 25, 2026

Packs & prices · 3

1 priced
  • no_merkevare_id
    ID_6CBDA88B-AB13-4893-8E75-91C826F835A4
  • no_varenummer
    541990
    1
    NOK 283.7
  • gtin
    8033638957677

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

1 interaction on record for chorionic gonadotrophin.

Graded by severity as the source publishes them — 1 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Chorionic gonadotrophin · interactions on record

1 record

  • 1 moderate

Most severe, free to view

  • GanirelixH01CC01moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d642b12b-b4ef-44cc-b0c2-f42a2c8140dc
GET /v1/drugs/d642b12b-b4ef-44cc-b0c2-f42a2c8140dc?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Pulver og væske til injeksjonsvæske, oppløsning",
  "source": "fest",
  "status": "A",
  "atc_name": "Koriongonadotropin",
  "merkevare_id": "ID_6CBDA88B-AB13-4893-8E75-91C826F835A4",
  "name_form_strength": "Gonasi Set pulv+væske til inj oppl 5000 IE",
  "prescription_group": "C"
}

See everything about chorionic gonadotrophin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.